Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial

J. Overgaard, C. M. Hoff, Hanne Sand Hansen, L. Specht, M. Overgaard, C. Grau, E. Andersen, Jørgen Johansen, L.J. Andersen, J.F. Evensen

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

OriginalsprogEngelsk
Publikationsdato2009
StatusUdgivet - 2009
Begivenhed2009 ASCO Annual Meeting - Orlando, USA
Varighed: 29. maj 20092. jun. 2009

Konference

Konference2009 ASCO Annual Meeting
LandUSA
ByOrlando
Periode29/05/200902/06/2009

Citer dette

Overgaard, J., Hoff, C. M., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., ... Evensen, J. F. (2009). Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial. Abstract fra 2009 ASCO Annual Meeting, Orlando, USA.
Overgaard, J. ; Hoff, C. M. ; Hansen, Hanne Sand ; Specht, L. ; Overgaard, M. ; Grau, C. ; Andersen, E. ; Johansen, Jørgen ; Andersen, L.J. ; Evensen, J.F. / Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial. Abstract fra 2009 ASCO Annual Meeting, Orlando, USA.
@conference{21b63d10d7b411deb0fe000ea68e967b,
title = "Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial",
author = "J. Overgaard and Hoff, {C. M.} and Hansen, {Hanne Sand} and L. Specht and M. Overgaard and C. Grau and E. Andersen and J{\o}rgen Johansen and L.J. Andersen and J.F. Evensen",
year = "2009",
language = "English",
note = "null ; Conference date: 29-05-2009 Through 02-06-2009",

}

Overgaard, J, Hoff, CM, Hansen, HS, Specht, L, Overgaard, M, Grau, C, Andersen, E, Johansen, J, Andersen, LJ & Evensen, JF 2009, 'Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial' 2009 ASCO Annual Meeting, Orlando, USA, 29/05/2009 - 02/06/2009, .

Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial. / Overgaard, J.; Hoff, C. M.; Hansen, Hanne Sand; Specht, L.; Overgaard, M.; Grau, C.; Andersen, E.; Johansen, Jørgen; Andersen, L.J.; Evensen, J.F.

2009. Abstract fra 2009 ASCO Annual Meeting, Orlando, USA.

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

TY - ABST

T1 - Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial

AU - Overgaard, J.

AU - Hoff, C. M.

AU - Hansen, Hanne Sand

AU - Specht, L.

AU - Overgaard, M.

AU - Grau, C.

AU - Andersen, E.

AU - Johansen, Jørgen

AU - Andersen, L.J.

AU - Evensen, J.F.

PY - 2009

Y1 - 2009

M3 - Conference abstract for conference

ER -

Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Grau C et al. Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial. 2009. Abstract fra 2009 ASCO Annual Meeting, Orlando, USA.